Cargando…
Cross-reactive tissue-resident CD8(+) T cells may provide first line of defence against SARS-CoV-2
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491448/ https://www.ncbi.nlm.nih.gov/pubmed/34611319 http://dx.doi.org/10.1038/s41577-021-00638-4 |